nsv5332171
- Organism: Homo sapiens
- Study:nstd200 (Abel et al. 2020)
- Variant Type:translocation
- Method Type:Sequencing
- Submitted on:GRCh37
- Variant Calls:1
- Validation:Not tested
- Clinical Assertions: No
- Region Size:1
- Publication(s):Abel et al. 2020
Source: NCBI
- Genome View
- Variant Region Details and Evidence
- Validation Information
- Clinical Assertions
- Genotype Information
Genome View
Select assembly:Overlapping variant regions from other studies: 159 SVs from 41 studies. See in: genome view
Overlapping variant regions from other studies: 119 SVs from 24 studies. See in: genome view
Overlapping variant regions from other studies: 21 SVs from 15 studies. See in: genome view
Overlapping variant regions from other studies: 159 SVs from 41 studies. See in: genome view
Overlapping variant regions from other studies: 119 SVs from 24 studies. See in: genome view
Variant Region Placement Information
| Variant Region ID | Placement Type | Score | Assembly | Assembly Unit | Reciprocity | Sequence ID | Chr | Start | Stop | strand |
|---|---|---|---|---|---|---|---|---|---|---|
| nsv5332171 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000004.12 | Chr4 | 79,973,318 | 79,973,318 | + |
| nsv5332171 | Remapped | Perfect | GRCh38.p12 | Primary Assembly | First Pass | NC_000014.9 | Chr14 | 44,792,639 | 44,792,639 | + |
| nsv5332171 | Remapped | Perfect | GRCh38.p12 | PATCHES | Second Pass | NW_009646199.1 | Chr5|NW_00 9646199.1 | 115,709 | 115,709 | + |
| nsv5332171 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000004.11 | Chr4 | 80,894,472 | 80,894,472 | + | ||
| nsv5332171 | Submitted genomic | GRCh37 (hg19) | Primary Assembly | NC_000014.8 | Chr14 | 45,261,842 | 45,261,842 | + |
Variant Call Information
| Variant Call ID | Type | Method | Analysis |
|---|---|---|---|
| nssv16415057 | interchromosomal translocation | Sequencing | Sequence alignment |
Variant Call Placement Information
| Variant Call ID | Placement Type | Score | Assembly | Reciprocity | Sequence ID | Chr | Start | Stop | strand |
|---|---|---|---|---|---|---|---|---|---|
| nssv16415057 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000004.12 | Chr4 | 79,973,318 | 79,973,318 | + |
| nssv16415057 | Remapped | Perfect | GRCh38.p12 | Second Pass | NW_009646199.1 | Chr5|NW_00 9646199.1 | 115,709 | 115,709 | + |
| nssv16415057 | Remapped | Perfect | GRCh38.p12 | First Pass | NC_000014.9 | Chr14 | 44,792,639 | 44,792,639 | + |
| nssv16415057 | Submitted genomic | GRCh37 (hg19) | NC_000004.11 | Chr4 | 80,894,472 | 80,894,472 | + | ||
| nssv16415057 | Submitted genomic | GRCh37 (hg19) | NC_000014.8 | Chr14 | 45,261,842 | 45,261,842 | + |
No validation data were submitted for this variant
No clinical assertion data were submitted for this variant
Genotype Information
| Variant Call ID | Allele Frequency (AF) | Allele Count (AC) | Allele Number (AN) |
|---|---|---|---|
| nssv16415057 | <0.001 | 1 | 16834 |